425: Strive CEO Posts on X Regarding Semler Merger Risks

Strive Inc.'s CEO Matthew Cole posted on X.com about the proposed business combination with Semler Scientific, Inc., reiterating the transaction's status and associated risks.

Summary

• Strive, Inc. CEO Matthew Cole communicated on X.com regarding the proposed business combination with Semler Scientific, Inc. on November 18, 2025.
• The communication serves as a public disclosure under SEC Rule 425, related to the ongoing merger process.
• It includes a cautionary statement about forward-looking statements, highlighting inherent risks and uncertainties regarding the transaction.
• The proposed transaction aims for strategic and financial benefits, successful integration, and timely closing, but these are subject to various risks.
• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus for the transaction.
• Investors and stockholders are urged to review the S-4 and other relevant SEC filings for comprehensive information before making any voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a cautionary communication about a proposed merger. While it mentions anticipated benefits, it heavily emphasizes numerous risks and uncertainties, balancing any positive sentiment with significant caveats.

Positives

• The proposed business combination is expected to yield strategic and financial benefits for the combined company.
• The transaction is anticipated to lead to successful integration of the combined businesses.

Negatives

• The proposed transaction may not close as expected or at all if conditions are not met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, particularly due to risks associated with Bitcoin treasury strategies and digital assets.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Strive's issuance of additional Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• Potential adverse reactions from customers or changes to business/employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price could happen before closing.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement between Strive and Semler Scientific.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction's success.
• The possibility that the integration of the two companies may be more difficult, time-consuming or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific or the combined company, including unknown or unpredictable factors.

Future Outlook

The proposed transaction is expected to bring strategic and financial benefits, successful integration, and a timely closing. However, these are forward-looking statements subject to significant risks and uncertainties, including the possibility that anticipated benefits may not be realized and integration could be more challenging or costly than expected. Investors are cautioned not to rely too heavily on these forward-looking statements.

Management Comments

• "Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied by such forward-looking statements."
• "Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that the actual results of Strive or Semler Scientific will not differ materially from any projected future results expressed or implied by such forward-looking statements."
• "Investors are cautioned not to rely too heavily on any such forward-looking statements."

Industry Context

This filing relates to a proposed merger between Strive, Inc. and Semler Scientific, Inc. The mention of 'Bitcoin treasury strategies' for the combined entity suggests an increasing trend among companies to integrate digital assets into their corporate finance strategies, which introduces new financial and operational risks. This strategic move could position the combined entity within the evolving landscape of digital asset adoption in corporate treasury management.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their business or employment relationships resulting from the announcement or completion of the proposed transaction.
• Investors are cautioned not to rely too heavily on forward-looking statements due to the inherent risks and uncertainties associated with the proposed merger.

Next Steps

• Strive and Semler Scientific will continue to work towards satisfying the conditions to closing the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury, Digital Assets, Share Dilution